The Problem With Drug Development Isn’t Regulation

LAGUNA NIGUEL, Calif.--The cost of failure for drug development is rising. The productivity gains seem elusive. And of course there are the economics, a pressure on drug pricing that won’t let up.

The “pipeline”--that is, the drug development process--is under fire at a time when medical science seems to be making leaps and bounds. What gives? Experts gathered over lunch here at Fortune’s Brainstorm Health conference to discuss.

“The efficiency of the industry in converting cash...

What feeling does this article give you?

#hashtags to follow:

LAGUNA NIGUEL [+]    Calif [+]    Brainstorm Health [+]   

More #news: